URS
MRNA icon

Utah Retirement Systems’s Moderna MRNA Stock Holding History

Utah Retirement Systems’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Sell
55,289
-2,968
-5% -$154K 0.04% 391
2026
Q1 		$2.96M Sell
58,257
-279
-0.5% -$13K 0.03% 457
2025
Q4 		$1.73M Hold
58,536
– – 0.02% 608
2025
Q3 		$1.51M Buy
58,536
+3,687
+7% +$103K 0.01% 636
2025
Q2 		$1.51M Buy
54,849
+1,567
+3% +$41.3K 0.02% 619
2025
Q1 		$1.51M Hold
53,282
– – 0.02% 617
2024
Q4 		$2.22M Hold
53,282
– – 0.02% 539
2024
Q3 		$3.56M Buy
53,282
+100
+0.2% +$9.18K 0.04% 391
2024
Q2 		$6.32M Sell
53,182
-4,400
-8% -$557K 0.08% 239
2024
Q1 		$6.14M Hold
57,582
– – 0.07% 269
2023
Q4 		$5.73M Buy
57,582
+300
+0.5% +$25.2K 0.07% 276
2023
Q3 		$5.92M Sell
57,282
-400
-0.7% -$44.6K 0.08% 241
2023
Q2 		$7.01M Sell
57,682
-1,400
-2% -$187K 0.1% 207
2023
Q1 		$9.07M Buy
59,082
+200
+0.3% +$33K 0.13% 153
2022
Q4 		$10.6M Sell
58,882
-1,700
-3% -$278K 0.17% 126
2022
Q3 		$7.16M Sell
60,582
-700
-1% -$106K 0.12% 171
2022
Q2 		$8.75M Buy
61,282
+900
+1% +$129K 0.14% 145
2022
Q1 		$10.4M Sell
60,382
-1,000
-2% -$168K 0.14% 146
2021
Q4 		$15.6M Buy
61,382
+137
+0.2% +$40.1K 0.19% 101
2021
Q3 		$23.6M Sell
61,245
-3,255
-5% -$1.2M 0.32% 60
2021
Q2 		$15.2M Buy
64,500
+9,800
+18% +$1.75M 0.2% 107
2021
Q1 		$7.16M Sell
54,700
-2,500
-4% -$362K 0.1% 200
2020
Q4 		$5.98M Buy
57,200
+2,500
+5% +$253K 0.08% 239
2020
Q3 		$3.87M Buy
54,700
+43,500
+388% +$3.03M 0.06% 296
2020
Q2 		$719K Buy
11,200
+1,800
+19% +$98.6K 0.01% 745
2020
Q1 		$282K Buy
+9,400
New +$216K 0.01% 869

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Utah Retirement Systems's MRNA Position: Q2 2026 in Review

Utah Retirement Systems reduced its Moderna (MRNA) stake by 5.1% in Q2 2026, selling an estimated $154K and leaving 55,289 shares worth $3.87M. The position accounts for 0.04% of the portfolio, ranked #391.

Utah Retirement Systems first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $23.6M in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Utah Retirement Systems held 55,289 shares of Moderna worth $3.87M as of Q2 2026.
  • Utah Retirement Systems sold 2,968 Moderna shares in Q2 2026, an estimated $154K.
  • Moderna made up 0.04% of Utah Retirement Systems's portfolio in Q2 2026, its #391 holding.
  • Utah Retirement Systems first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Utah Retirement Systems's Moderna position peaked at $23.6M in Q3 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.